Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Identifying High-Impact and Managing Low-Impact Assessment Practices.

Janke KK, Kelley KA, Martin BA, Ray ME, Sweet BV.

Am J Pharm Educ. 2019 Sep;83(7):7496. doi: 10.5688/ajpe7496.

2.

Best Practices Related to Examination Item Construction and Post-hoc Review.

Rudolph MJ, Daugherty KK, Ray ME, Shuford VP, Lebovitz L, DiVall MV.

Am J Pharm Educ. 2019 Sep;83(7):7204. doi: 10.5688/ajpe7204. Review.

3.

Quantitative and Qualitative Factors Associated with Social Isolation Among Graduate and Professional Health Science Students.

Ray ME, Coon JM, Al-Jumaili AA, Fullerton M.

Am J Pharm Educ. 2019 Sep;83(7):6983. doi: 10.5688/ajpe6983.

4.

Incorporating LGBTQ health into the curriculum: Assessment of student pharmacists' knowledge and comfort level in caring for transgender patients.

Knockel LE, Ray ME, Miller ML.

Curr Pharm Teach Learn. 2019 Sep;11(9):928-935. doi: 10.1016/j.cptl.2019.07.001. Epub 2019 Aug 2.

PMID:
31570131
5.

A latent change score analysis of emotion regulation difficulties and evaluative threat in STEM.

Rice KG, Montfort AK, Ray ME, Davis DE, DeBlaere C.

J Couns Psychol. 2019 Mar;66(2):158-169. doi: 10.1037/cou0000325. Epub 2019 Jan 17.

PMID:
30652882
6.

Best Practices on Examination Construction, Administration, and Feedback.

Ray ME, Daugherty KK, Lebovitz L, Rudolph MJ, Shuford VP, DiVall MV.

Am J Pharm Educ. 2018 Dec;82(10):7066. doi: 10.5688/ajpe7066.

7.

Preventing Unintended Adolescent Pregnancy.

Klein DA, Ray ME.

Am Fam Physician. 2017 Apr 1;95(7):422-423. No abstract available.

8.

A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy.

Jackson WC, Feng FY, Daignault S, Hussain M, Smith D, Cooney K, Pienta K, Jolly S, Hollenbeck B, Olson KB, Sandler HM, Ray ME, Hamstra DA.

Adv Radiat Oncol. 2015 Dec 9;1(1):59-66. doi: 10.1016/j.adro.2015.11.001. eCollection 2016 Jan-Mar.

9.

Perfectionism and longitudinal patterns of stress for STEM majors: Implications for academic performance.

Rice KG, Ray ME, Davis DE, DeBlaere C, Ashby JS.

J Couns Psychol. 2015 Oct;62(4):718-31. doi: 10.1037/cou0000097. Epub 2015 Jul 13.

PMID:
26167648
10.

Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy.

Vainshtein J, Abu-Isa E, Olson KB, Ray ME, Sandler HM, Normolle D, Litzenberg DW, Masi K, Pan C, Hamstra DA.

Radiat Oncol. 2012 Jun 9;7:82. doi: 10.1186/1748-717X-7-82.

11.

Potential surrogate endpoints for prostate cancer survival: analysis of a phase III randomized trial.

Ray ME, Bae K, Hussain MH, Hanks GE, Shipley WU, Sandler HM.

J Natl Cancer Inst. 2009 Feb 18;101(4):228-36. doi: 10.1093/jnci/djn489. Epub 2009 Feb 10.

12.

Inhibition of mTOR radiosensitizes soft tissue sarcoma and tumor vasculature.

Murphy JD, Spalding AC, Somnay YR, Markwart S, Ray ME, Hamstra DA.

Clin Cancer Res. 2009 Jan 15;15(2):589-96. doi: 10.1158/1078-0432.CCR-08-1019.

13.

No effect of statins on biochemical outcomes after radiotherapy for localized prostate cancer.

Soto DE, Daignault S, Sandler HM, Ray ME.

Urology. 2009 Jan;73(1):158-62. doi: 10.1016/j.urology.2008.02.055. Epub 2008 Aug 22.

PMID:
18722651
14.

Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer.

Woods Ignatoski KM, Grewal NK, Markwart SM, Vellaichamy A, Chinnaiyan AM, Yeung K, Ray ME, Keller ET.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):153-60. doi: 10.1016/j.ijrobp.2008.04.072.

15.

Gemcitabine-mediated radiosensitization of human soft tissue sarcoma.

Murphy JD, Lucas DR, Somnay YR, Hamstra DA, Ray ME.

Transl Oncol. 2008 Mar;1(1):50-6.

16.

Impact of common iliac nodal treatment on radiation outcomes in localized prostate cancer.

Soto DE, Glaser S, Roberts RH, Schipper MJ, McLaughlin PW, Ray ME, Sandler HM, Pan CC.

Urology. 2008 Feb;71(2):313-7. doi: 10.1016/j.urology.2007.08.037.

PMID:
18308110
17.

Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcoma.

Feng M, Murphy J, Griffith KA, Baker LH, Sondak VK, Lucas DR, McGinn CJ, Ray ME.

Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):103-10. Epub 2007 Jun 7.

PMID:
17560050
18.

Percent positive biopsy cores as a prognostic factor for prostate cancer treated with external beam radiation.

Spalding AC, Daignault S, Sandler HM, Shah RB, Pan CC, Ray ME.

Urology. 2007 May;69(5):936-40.

PMID:
17482938
19.

Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer.

Murphy JD, Adusumilli S, Griffith KA, Ray ME, Zalupski MM, Lawrence TS, Ben-Josef E.

Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):801-8. Epub 2007 Mar 26.

PMID:
17379445
20.

Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer.

Yang ZQ, Streicher KL, Ray ME, Abrams J, Ethier SP.

Cancer Res. 2006 Dec 15;66(24):11632-43.

21.

Targeted and systemic radiotherapy in the treatment of bone metastasis.

Lin A, Ray ME.

Cancer Metastasis Rev. 2006 Dec;25(4):669-75. Review.

PMID:
17160556
22.

Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure.

Ray ME, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Zelefsky MJ, Zietman AL, Kuban DA.

Urology. 2006 Dec;68(6):1257-62. Epub 2006 Dec 4.

PMID:
17141830
23.

E-cadherin protein expression predicts prostate cancer salvage radiotherapy outcomes.

Ray ME, Mehra R, Sandler HM, Daignault S, Shah RB.

J Urol. 2006 Oct;176(4 Pt 1):1409-14; discussion 1414.

PMID:
16952645
24.

Radiation therapy for aggressive fibromatosis (desmoid tumor).

Ray ME, Lawrence TS.

J Clin Oncol. 2006 Aug 1;24(22):3714-5; author reply 3715. No abstract available.

PMID:
16877745
25.

Primary versus radiation-associated craniofacial osteosarcoma: Biologic and clinicopathologic comparisons.

McHugh JB, Thomas DG, Herman JM, Ray ME, Baker LH, Adsay NV, Rabah R, Lucas DR.

Cancer. 2006 Aug 1;107(3):554-62.

26.

Cochlear implantation with ipsilateral petroclival chondrosarcoma.

Lin EM, Ray ME, Telian SA.

Otol Neurotol. 2006 Apr;27(3):337-41.

PMID:
16639271
27.

Clonality of sarcomatous and carcinomatous elements in sarcomatoid carcinoma of the prostate.

Ray ME, Wojno KJ, Goldstein NS, Olson KB, Shah RB, Cooney KA.

Urology. 2006 Feb;67(2):423.e5-423.e8.

PMID:
16461109
28.

PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis.

Ray ME, Thames HD, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Shipley WU, Zelefsky MJ, Zietman AL, Kuban DA.

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1140-50. Epub 2005 Sep 29.

PMID:
16198506
29.

Adjuvant therapy for soft tissue sarcoma.

Schuetze SM, Ray ME.

J Natl Compr Canc Netw. 2005 Mar;3(2):207-13. Review.

PMID:
19817030
30.

Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines.

Ray ME, Yang ZQ, Albertson D, Kleer CG, Washburn JG, Macoska JA, Ethier SP.

Cancer Res. 2004 Jan 1;64(1):40-7.

31.

Family history of prostate cancer and relapse after definitive external beam radiation therapy.

Ray ME, Dunn RL, Cooney KA, Sandler HM.

Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):371-6.

PMID:
12957247
32.

Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX.

Lange EM, Chen H, Brierley K, Perrone EE, Bock CH, Gillanders E, Ray ME, Cooney KA.

Clin Cancer Res. 1999 Dec;5(12):4013-20.

33.

Cloning and tissue expression of the mouse ortholog of AIM1, a betagamma-crystallin superfamily member.

Teichmann U, Ray ME, Ellison J, Graham C, Wistow G, Meltzer PS, Trent JM, Pavan WJ.

Mamm Genome. 1998 Sep;9(9):715-20.

PMID:
9716656
34.

Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma.

DeYoung KL, Ray ME, Su YA, Anzick SL, Johnstone RW, Trapani JA, Meltzer PS, Trent JM.

Oncogene. 1997 Jul 24;15(4):453-7.

35.
36.

Isolation of chromosome-specific ESTs by microdissection-mediated cDNA capture.

Gracia E, Ray ME, Polymeropoulos MH, Dehejia A, Meltzer PS, Trent JM.

Genome Res. 1997 Feb;7(2):100-7.

37.

Reversion of monochromosome-mediated suppression of tumorigenicity in malignant melanoma by retroviral transduction.

Su YA, Ray ME, Lin T, Seidel NE, Bodine DM, Meltzer PS, Trent JM.

Cancer Res. 1996 Jul 15;56(14):3186-91.

38.
39.
40.

Recruitment--5. The role of an advertising agency in the recruitment exercise.

Ray ME.

Nurs Times. 1980 Oct 16;76(42):1852-4. No abstract available.

PMID:
6903950
41.

Use of catheter-tip velocity--pressure transducer to evaluate left ventricular function in man: effects of intravenous propranolol.

Klinke WP, Christie LG, Nichols WW, Ray ME, Curry RC, Pepine CJ, Conti CR.

Circulation. 1980 May;61(5):946-54.

PMID:
7363437
42.

Presentation to Miss Ray.

Ray ME.

Hospital (Lond 1886). 1918 Dec 14;65(1697):228. No abstract available.

43.

The College of Nursing, Limited, and State Registration of Nurses.

Stanley A, Baillie AB, Barton E, Cantlie J, Cox-Davies R, Gibson AC, Gill AW, Glaister J, Hughes A, McIntosh A, Melrose J, Berkeley C, Minet W, Mowat EW, Musson EM, Ray ME, Sparshott ME, Still AL, Swift SA, Turney HG, Vincent CE, Walker J, Perry EC.

Hospital (Lond 1886). 1916 Nov 25;61(1590):169. No abstract available.

Supplemental Content

Support Center